Composite Hepatocellular Carcinoma and Small Cell Carcinoma with Early Nodal Metastasis: A Case Report
Overview
Affiliations
Rationale: Hepatocellular carcinoma (HCC) is known to grow in a mosaic pattern, and it can sometimes be combined with non-hepatocellular cells. Despites the variety of combination, HCC with a significant neuroendocrine carcinoma (NEC) component remains very rare. Most of the reported cases were treated as conventional HCC with a relatively poor prognosis. Early diagnosis may lead to a better treatment modality. Here, we report a case of composite HCC and small cell carcinoma (SCC) with nodal metastasis of the SCC component alone.
Patient Concerns: A 65-year-old man with chronic viral hepatitis C presented with abdominal discomfort for 2 months. Computed tomography and angiography of the liver showed a 4.3 cm hypervascular tumor in segment 4 and enlargement of the perihilar and paracaval lymph nodes.
Interventions: Extended left lobectomy and regional lymph node dissection were performed.
Diagnosis: The hepatic tumor was heterogeneous with two distinct gross components. The green part showed a grade III hepatocellular carcinoma with an immunoreaction to Hep Par 1, glypican 3 and α-fetoprotein, whereas the white part exhibited a small cell carcinoma, as evidenced by expressions of chromogranin A and synaptophysin. The lymph node was metastasized by the SCC component. The SCC part was also positive for vimentin with perivascular accentuation. ß-catenin immunostain showed reduced membranous expression in the SCC component, as compared to HCC.
Outcomes: The patient expired 39 days after the surgical intervention.
Lessons: Clinicians should be highly alert to a composite hepatic tumor, especially in dealing with a small heterogeneous tumor (< 5 cm) with early lymph node metastasis.
Mubeen B, Eapen M, Sudhindran S, Haridas N Turk Patoloji Derg. 2024; 41(1):21-29.
PMID: 39268996 PMC: 11831964. DOI: 10.5146/tjpath.2024.13492.
Case report: mixed large-cell neuroendocrine and hepatocellular carcinoma of the liver.
Gao X, Wang H, Niu Z, Liu M, Kong X, Sun H Front Oncol. 2024; 13:1309798.
PMID: 38264742 PMC: 10803416. DOI: 10.3389/fonc.2023.1309798.
Shin W, Lee K, Kim K Medicina (Kaunas). 2023; 59(2).
PMID: 36837619 PMC: 9959776. DOI: 10.3390/medicina59020418.
Jeng K, Huang C, Chung C, Chang C World J Clin Cases. 2022; 10(35):13129-13137.
PMID: 36569002 PMC: 9782927. DOI: 10.12998/wjcc.v10.i35.13129.
Tang J, Zhang L, Kang M, Huang R, Shu H, Wei H Front Genet. 2022; 13:1010903.
PMID: 36199582 PMC: 9527270. DOI: 10.3389/fgene.2022.1010903.